BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32147984)

  • 1. Brain 18F-FDG-PET: Utility in the Diagnosis of Dementia and Epilepsy.
    Lotan E; Friedman KP; Davidson T; Shepherd TM
    Isr Med Assoc J; 2020 Mar; 22(3):178-184. PubMed ID: 32147984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management impact of FDG-PET in dementia: results from a tertiary center memory clinic.
    Elias A; Woodward M; Rowe CC
    J Alzheimers Dis; 2014; 42(3):885-92. PubMed ID: 24961944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of 18F-FDG-PET/MRI brain in dementia: Preliminary experience from a geriatric clinic in South India.
    Mukku SSR; Sivakumar PT; Nagaraj C; Mangalore S; Harbishettar V; Varghese M
    Asian J Psychiatr; 2019 Aug; 44():99-105. PubMed ID: 31336358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in presurgical localization of epileptic foci.
    Csaba J
    Ideggyogy Sz; 2003 Jul; 56(7-8):249-54. PubMed ID: 12971120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
    Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
    Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Use of Integrated Positron Emission Tomography-Magnetic Resonance Imaging for Dementia Patients.
    Shepherd TM; Nayak GK
    Top Magn Reson Imaging; 2019 Dec; 28(6):299-310. PubMed ID: 31794502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presurgical evaluation of pediatric epilepsy patients prior to hemispherotomy: the prognostic value of
    Traub-Weidinger T; Weidinger P; Gröppel G; Karanikas G; Wadsak W; Kasprian G; Dorfer C; Dressler A; Muehlebner A; Hacker M; Czech T; Feucht M
    J Neurosurg Pediatr; 2016 Dec; 25(6):683-688. PubMed ID: 27611898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epilepsy Lesion Localization is not Predicted by Developmental Venous Anomaly Location or its FDG-PET Metabolic Activity.
    Lazor JW; Stein JM; Schmitt JE; Davis KA; Nabavizadeh SA
    J Neuroimaging; 2020 Jul; 30(4):544-550. PubMed ID: 32384221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autopsy as gold standard in FDG-PET studies in dementia.
    Durand-Martel P; Tremblay D; Brodeur C; Paquet N
    Can J Neurol Sci; 2010 May; 37(3):336-42. PubMed ID: 20481267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.
    Lan MJ; Ogden RT; Kumar D; Stern Y; Parsey RV; Pelton GH; Rubin-Falcone H; Pradhaban G; Zanderigo F; Miller JM; Mann JJ; Devanand DP
    J Alzheimers Dis; 2017; 60(3):939-947. PubMed ID: 28984586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of interictal (18)F-fluorodeoxyglucose (FDG)-PET and magnetoencephalography (MEG) to localize epileptogenic foci in non-lesional epilepsy in a cohort of 16 patients.
    Wang Y; Liu B; Fu L; Cui Z
    J Neurol Sci; 2015 Aug; 355(1-2):120-4. PubMed ID: 26066558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia.
    Sawyer DM; Kuo PH
    Clin Nucl Med; 2018 Jun; 43(6):e212-e214. PubMed ID: 29659399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidance for reading FDG PET scans in dementia patients.
    Herholz K
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):332-43. PubMed ID: 25391316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy.
    Liew CJ; Lim YM; Bonwetsch R; Shamim S; Sato S; Reeves-Tyer P; Herscovitch P; Dustin I; Bagic A; Giovacchini G; Theodore WH
    Epilepsia; 2009 Feb; 50(2):234-9. PubMed ID: 18801033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy.
    Rubí S; Setoain X; Donaire A; Bargalló N; Sanmartí F; Carreño M; Rumià J; Calvo A; Aparicio J; Campistol J; Pons F
    Epilepsia; 2011 Dec; 52(12):2216-24. PubMed ID: 22050207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of
    Ortner MM
    Methods Mol Biol; 2018; 1750():213-219. PubMed ID: 29512075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.